Royalty Pharma Acquires a Portion of New York University’s Royalty Interest in Remicade® for $650 Million

New York, NY, May 4, 2007 – Royalty Pharma and New York University (NYU) announced today that NYU has sold a portion of NYU’s worldwide royalty interest in Remicade® to Royalty Pharma.

Source: Original Article